Navigation Links
According to a New Government Survey, 38 Percent of Adults and 12 Percent of Children Use Complementary and Alternative Medicine
Date:12/10/2008

ears: 44.1 percent, 60-69 years: 41.0 percent)
  • Those with higher levels of education (Masters, doctorate or professional: 55.4 percent)
  • Those who were not poor (poor: 28.9 percent, near poor: 30.9 percent, not poor: 43.3 percent)
  • Those living in the West (44.6 percent)
  • Those who have quit smoking (48.1 percent).
  • CAM Use Among Children

    Overall, CAM use among children is nearly 12 percent, or about 1 in 9 children. Children are five times more likely to use CAM if a parent or other relative uses CAM. Other characteristics of adult and child CAM users are similar --- factors such as socioeconomic status, geographic region, the number of health conditions, the number of doctor visits in the last 12 months, and delaying or not receiving conventional care because of cost are all associated with CAM use.

    Among children who used CAM in the past 12 months, CAM therapies were used most often for back or neck pain, head or chest colds, anxiety or stress, other musculoskeletal problems, and Attention Deficit/Hyperactivity Disorder (ADD/ADHD).

    The most commonly used CAM therapies among children were

    • Nonvitamin, nonmineral, natural products (3.9 percent)

    Most common: echinacea, fish oil/omega 3/DHA, combination herb pill, flaxseed oil or pills, and prebiotics or probiotics

    • Chiropractic or osteopathic manipulation (2.8 percent)
    • Deep breathing exercises (2.2 percent)
    • Yoga (2.1 percent).

    "The survey results provide information on trends and a rich set of data for investigating who in America is using CAM, the practices they use, and why," said Richard L. Nahin, Ph.D., MPH, acting director of NCCAM's Division of Extramural Research and co-au
    '/>"/>

    SOURCE National Institutes of Health; National Center for Complementary and Alternative Medicine
    Copyright©2008 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine news :

    1. Chicago Sit-In Highlights Laid-Off Workers, Employers Obligations, and WARN Act, According to Outten & Golden LLP
    2. Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial
    3. Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks
    4. Economy Doesnt Dampen Colorados Giving Spirit According to Statewide Giving and Volunteering Study
    5. Enrollment Growth in U.S. Nursing Colleges and Universities Hits an 8-Year Low According to New Data Released by AACN
    6. Medtronic, Inc. and Medtronic Sofamor Danek, USA, Inc. Sued for Product Liability and Promoting the Off-Label Use of Infuse(R) Bone Graft Product, According to Page Perry, LLC
    7. Cancer incidence and mortality drops among American men and women, according to annual report
    8. Oregon, Washington State Doing the Most to Promote Roadway Safety, According to New Emergency Nurses Association National Scorecard
    9. More Than Half of Consumers Going to Doctors Less Due to Rising Healthcare Costs, According to checkMD Survey : 38 Percent Lack Adequate Employer Healthcare Coverage
    10. Pharmaceutical Industry Needs to Speed Up Transformation to Meet Changing Market Dynamics, According to Ernst & Young Report
    11. Companies Pay a High Price for Employees With Crohns Disease and Ulcerative Colitis, According to Study From Thomson Reuters
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Breaking Medicine Technology:Royalty Pharma Announces that Alexander von Perfall Joins Management Team 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Simulation helps students learn dental implant procedures 48631 1Simulation helps students learn dental implant procedures 48631 2Simulation helps students learn dental implant procedures 48631 3U S Drug Czar Addresses 2 500 Drug Court Professionals Voices Strong Support for Expanding Drug Courts Throughout the Nation 48628 1U S Drug Czar Addresses 2 500 Drug Court Professionals Voices Strong Support for Expanding Drug Courts Throughout the Nation 48628 2U S Drug Czar Addresses 2 500 Drug Court Professionals Voices Strong Support for Expanding Drug Courts Throughout the Nation 48628 3Are angiotensins involved in the hemodynamic changes of cirrhosis patients 3F 48625 1Are angiotensins involved in the hemodynamic changes of cirrhosis patients 3F 48625 2